Overview
Clinical interests include pediatric and adult congenital interventional cardiac catheterization and treatment of infants and children with acquired and congenital heart disease and adults with congenital heart disease
Research interests include assessment and development of interventional therapies for congenital heart disease, and perioperative management of infants and children with congenital heart disease requiring surgery.
Research interests include assessment and development of interventional therapies for congenital heart disease, and perioperative management of infants and children with congenital heart disease requiring surgery.
Current Appointments & Affiliations
Professor of Pediatrics
·
2022 - Present
Pediatrics, Cardiology,
Pediatrics
Recent Publications
Additive value of invasive haemodynamic assessment for predicting post-operative outcomes after Fontan.
Journal Article Cardiol Young · October 2024 Routine pre-Fontan cardiac catheterization remains standard practice at most centres. However, with advances in non-invasive risk assessment, an invasive haemodynamic assessment may not be necessary for all patients.Using retrospective data from patients u ... Full text Link to item CiteUsefulness of PREDIC3T Case Type Risk Category in the CRISP Registry.
Journal Article Am J Cardiol · February 1, 2024 Procedural risk in Congenital Cardiac Catheterization (PREDIC3T) was recently reported as the contemporary procedure-type risk metric by the Congenital Cardiac Catheterization Project on Outcomes (C3PO) registry. The usefulness of this metric has not been ... Full text Link to item CiteThe Effect of Udenafil on Heart Rate and Blood Pressure in Adolescents With the Fontan Circulation.
Journal Article Am J Cardiol · January 1, 2024 The Fontan Udenafil Exercise Longitudinal (FUEL) trial showed that treatment with udenafil was associated with improved exercise performance at the ventilatory anaerobic threshold in children with Fontan physiology. However, it is not known how the initiat ... Full text Link to item CiteRecent Grants
Harmony PAS
Clinical TrialPrincipal Investigator · Awarded by Medtronic, Inc. · 2022 - 2031Evaluation of the safety and efficacy of the reSept ASD Occluder to treat patients with clinically significant secundum atrial septal defect (ASCENT ASD STUDY)
Clinical TrialPrincipal Investigator · Awarded by AtHeart Medical · 2024 - 2028Fontan Udenafil Exercise Longitudinal Assessment Trial (the FUEL-2 Study) Phase 3 study, to evaluate the clinical efficacy and safety of udenafil, an orally administered, potent and selective inhibitor of phosphodiesterase type 5 (PDE5)
Clinical TrialPrincipal Investigator · Awarded by Mezzion Pharma Co., LTD · 2024 - 2026View All Grants
Education, Training & Certifications
University of South Carolina, Columbia ·
2003
M.D.